We’re focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives. The European Commission (EC) approves our CRISPR-based treatment for sickle cell disease and transfusion-dependent beta thalassemia for the European Union. Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases. Learn more about how we're dedicated to being responsible global citizens from Executive Director Katharine Jensen.
Boston, United States
Founded in 1989
1001-5000 Employees
Working industry
Biotechnology
Type of company
Educational institution
Ownership structure
Public Company
Locations
5 Locations
Number of products
1 Product
Specialised areas
Scientific Research and Development Services, Manufacturing, Pharmaceutical preparations Biotechnical research, commercial, Pharmaceutical, Pharmaceutical preparations, Medical, Biotechnology, Chemical Manufacturing, Pharmaceutical and Medicine Manufacturing, Health Care
Vertex Pharmaceuticals offers a wide range of products and services
Product
Vertex Pharmaceuticals | Medicines | Reporting Adverse Events and/or Product Complaints
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Vertex Pharmaceuticals operates in 4 countries around the world
Get an overview of the locations of Vertex Pharmaceuticals
Location
Country
State
City
Headquarter
United States
Massachusetts
Boston
Research & Development Site
United States
California
San Diego
Research & Development Site
United Kingdom
-
-
Spain Office
Spain
Community of Madrid
Madrid
Australia Office
Australia
New South Wales
Sydney
Some frequent questions that have been asked about Vertex Pharmaceuticals
Where is Vertex Pharmaceuticals located?
The company headquarter of Vertex Pharmaceuticals is located in Boston, Massachusetts, United States. Vertex Pharmaceuticals has subsidiaries in United States, United Kingdom, Spain, Australia
How many employees does Vertex Pharmaceuticals approximately have?
As of the latest available information Vertex Pharmaceuticals has around 1001-5000 employees worldwide.
When was Vertex Pharmaceuticals founded?
Vertex Pharmaceuticals was founded in 1989
In which industries does Vertex Pharmaceuticals mainly work?
The company Vertex Pharmaceuticals has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to Vertex Pharmaceuticals
BridgeBio Pharma
Palo Alto, United States
251-500 Employees
2014
To discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The opportunity to help patients with genetic disease is vast. There are more than 8,000 diseases caused by a single genetic mutation. In total they affect tens of millions of people, but less than 50 FDA approved therapies exist to treat this class of conditions. By capitalizing on scientific advancements that deepen our understanding of genetic diseases, we have the potential to develop breakthrough medicines for patients in need at an unprecedented scale.
Kriya Therapeutics
Palo Alto, United States
51-100 Employees
2019
We are developing life-changing gene therapies for conditions affecting millions of people around the world. Our mission is to make gene therapies accessible – not just for the few – but for the many. We are located in Palo Alto, California and Research Triangle Park, North Carolina. We are backed by leading healthcare and technology investors who are committed to our goal of building the world’s leading gene therapy biopharmaceutical company. We target validated biological pathways with innovative gene therapy approaches that have the potential to deliver transformative benefits.
Scopus BioPharma
New York, United States
1-10 Employees
2018
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we are capitalizing on groundbreaking scientific and medical discoveries at some of the world’s foremost research and academic institutions.
Celgene
United States
10001+ Employees
1986
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. Our shared values are central to who we are, what we do and how we do it.
StrideBio
Durham, United States
51-100 Employees
2015
Our mission is to develop best-in-class gene therapies for people with life-threatening diseases. Our vision is to be the leader in the evolution of gene therapy and be known for superior drug development, high industry standards, extraordinary integrity and an innovative team that translates science into treatments that prolong and improve lives.
CRISPR Therapeutics
Cambridge, United States
101-250 Employees
2013
We are pioneering a new era of medicines. We are pioneers of the CRISPR technology and at the forefront of what’s next. The first-ever CRISPR-based therapy is a direct reflection of our patient-forward philosophy. We believe this once-in-a-generation breakthrough will make an impact for generations to come. CRISPR Therapeutics is founded, launching the growth of our team focused on translating the CRISPR/Cas9 discovery into potential therapeutics. Opens the doors to its own manufacturing facility in Framingham, Massachusetts. Where we’ve built our state-of-the-art, award-winning manufacturing facility.*. Here we focus on the most advanced gene editing and delivery technologies of the future.